Earnings Bioventus Sets Ambitious Targets Following Strong Fiscal Close
Medical technology firm Bioventus concluded its 2025 fiscal year with robust fourth-quarter performance, surpassing analyst consensus on key financial metrics. The company’s improved cash generation and confident guidance for 2026...